Pulmonary hypertension – Related resources
27.01.2013 • Sonuncu dəyişiklik 11.11.2010
This article is created and updated by the EBMG Editorial Team
Cochrane reviews
- Intravenous prostacyclin over 12 weeks appears to improve exercise capacity, NYHA functional class and several cardiopulmonary haemodynamic variables in patients with pulmonary hypertension .
The use of appetite suppressing medications may increase the risk of the disease .
Clinical guidelines
- Galiè N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL et al. Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J 2009;30(20):2493-537.
- McLaughlin VV, Archer SL, Badesch DB et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association. J Am Coll Cardiol 2009 Apr 28;53(17):1573-619.
Other Internet resources
- Idiopathic and/or familial pulmonary arterial hypertension. Orphanet ORPHA422
Literature
- Archer SL, Michelakis ED. Phosphodiesterase type 5 inhibitors for pulmonary arterial hypertension. N Engl J Med 2009 Nov 5;361(19):1864-71.